Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Eckhardt

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Nature Communications|March 15, 2024
Theory of resonantly enhanced photo-induced superconductivityChristian J Eckhardt, Sambuddha Chattopadhyay, Dante M Kennes, et al.
Open Forum Infectious Diseases|April 25, 2025
Providers' Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative StudyAne-Kristine Finbråten, Cristina L Chin, Meenakshi Seetharaman, et al.
British Journal of Cancer|May 17, 2012
c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cellsC S Tudor, C W Dawson, J Eckhardt, et al.
Physical Review Letters|October 25, 2025
Surface-Mediated Ultrastrong Cavity Coupling of Two-Dimensional Itinerant ElectronsChristian J Eckhardt, Andrey Grankin, Dante M Kennes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 17, 1999
Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosisD C Mohr, D E Goodkin, L Masuoka, et al.
AJNR. American Journal of Neuroradiology|March 1, 1988
Spinal neuroarthropathy after traumatic paraplegiaJ R Crim, L W Bassett, R H Gold, et al.
Clinical and Experimental Immunology|March 11, 2015
Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitisJ Eckhardt, M Döbbeler, C König, et al.
Harm Reduction Journal|July 27, 2023
"Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York CityShashi N Kapadia, Yesenia Aponte-Melendez, Alicia Rodriguez, et al.
Drug and Alcohol Dependence Reports|January 16, 2023
Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trialShashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, et al.
Plos One|November 23, 2020
Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020)Thomas D Filardo, Maria R Khan, Noa Krawczyk, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Nature Communications|March 15, 2024
Theory of resonantly enhanced photo-induced superconductivityChristian J Eckhardt, Sambuddha Chattopadhyay, Dante M Kennes, et al.
Open Forum Infectious Diseases|April 25, 2025
Providers' Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative StudyAne-Kristine Finbråten, Cristina L Chin, Meenakshi Seetharaman, et al.
British Journal of Cancer|May 17, 2012
c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cellsC S Tudor, C W Dawson, J Eckhardt, et al.
Physical Review Letters|October 25, 2025
Surface-Mediated Ultrastrong Cavity Coupling of Two-Dimensional Itinerant ElectronsChristian J Eckhardt, Andrey Grankin, Dante M Kennes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 17, 1999
Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosisD C Mohr, D E Goodkin, L Masuoka, et al.
AJNR. American Journal of Neuroradiology|March 1, 1988
Spinal neuroarthropathy after traumatic paraplegiaJ R Crim, L W Bassett, R H Gold, et al.
Clinical and Experimental Immunology|March 11, 2015
Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitisJ Eckhardt, M Döbbeler, C König, et al.
Harm Reduction Journal|July 27, 2023
"Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York CityShashi N Kapadia, Yesenia Aponte-Melendez, Alicia Rodriguez, et al.
Drug and Alcohol Dependence Reports|January 16, 2023
Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trialShashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, et al.
Plos One|November 23, 2020
Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020)Thomas D Filardo, Maria R Khan, Noa Krawczyk, et al.
Pageof 5